Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: Comparison with 99mTc-DTPA autoradiography in rats

Radiology

Volumn 211, Issue 3, 1999, Pages 698-708

  Arheden, Håkan ^a   Saeed, Maythem ^a   Higgins, Charles B ^a   Gao, Dong Wei ^a   Bremerich, Jens ^a   Wyttenbach, Rolf ^a   Dae, Michael W ^a   Wendland, Michael F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Heart, experimental studies; Magnetic resonance (MR), contrast enhancement; Magnetic resonance (MR), echo planar; Myocardium, infarction; Myocardium, ischemia; Radionuclide imaging, experimental studies

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE; PENTETATE TECHNETIUM TC 99M; RADIOISOTOPE;

ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOACTIVITY; RAT; SCINTILLATION COUNTING;

EID: 0033005256     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.211.3.r99jn41698     Document Type: Article

References (47)

1. Hale SL, Kloner RA. Effect of early coronary artery reperfusion on infarct development in a model of low collateral flow. Circ Res 1987; 21:668-673.
2. Garcia-Dorado D, Théroux P, Elizaga J, et al. Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion. Cardiovasc Res 1987; 21: 537-544.
3. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996; 36:684-693.
4. Lima JA, Judd RM, Bazille A, Schulman SR, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 1995; 92:1117-1125.
5. Tong CY, Prato FS, Wisenberg G, et al. Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 1993; 30:337-346.
6. Saeed M, Wendland MF, Masui T, Higgins CB. Reperfused myocardial infarctions on T1- and susceptibility-enhanced MRI: evidence for loss of compartmentalization of contrast media. Magn Reson Med 1994; 31:31-39.
7. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94:3318-3326.
8. Geschwind JF, Wendland MF, Saeed M, Lauerma K, Derugin N, Higgins CB. Identification of myocardial cell death in reperfused myocardial injury using dual mechanisms of contrast-enhanced magnetic resonance imaging. Acad Radiol 1994; 1: 319-325.
9. Nilsson S, Wikström G, Ericsson M, Wikström M, Waldenström A, Hemmingsson A. MR imaging of gadolinium-DTPA-BMA-enhanced reperfused and non-reperfused porcine myocardial infarction. Acta Radiol 1995; 36:633-640.
10. Diesbourg LD, Prato FS, Wisenberg G, et al. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992; 23:239-253.
11. Donahue KM, Burstein D, Manning WJ, Gray ML. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994; 32:66-76.
12. Wendland MF, Saeed M, Lauerma K, et al. Alterations in T1 of normal and reperfused infarcted myocardium after Gd-BOPTA versus Gd-DTPA on inversion recovery EPI. Magn Reson Med 1997; 37: 448-456.
13. Mosher P, Ross J, McFate PA, Shaw RF. Control of coronary blood flow by an autoregulatory mechanism. Circ Res 1964; 14:250-259.
14. Guyton RA, McClenathan JH, Newman GE, Michaelis LL. Significance of subendo-cardial S-T segment elevation caused by coronary stenosis in the dog. Am J Cardiol 1977; 40:373-380.
15. Birnbaum Y, Hale SL, Kloner RA. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining. J Mol Cell Cardiol 1997; 29:657-666.
16. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1:307-310.
17. Ziegler WH, Goresky CA. Transcapillary exchange in the working left ventricle of the dog. Circ Res 1971; 29:181-207.
18. Polimeni PI. Extracellular space and ionic distribution in rat ventricle. Am J Physiol 1974; 227:676-683.
19. Poole-Wilson PA, Cameron IR. ECS, intracellular pH, and electrolytes of cardiac and skeletal muscle. Am J Physiol 1975; 229:1299-1304.
20. Harris TR, Burks DD, Custer PL. Coronary capillary permeability and tissue volumes for sucrose and water in dogs: a comparison of bolus and constant infusion multiple indicator techniques. Cardiovasc Res 1978; 12:537-546.
21. Macchia DD, Page E, Polimeni PI. Interstitial anion distribution in striated muscle determined with [35S]sulfate and [3H]sucrose. Am J Physiol 1979; 237:C125-130.
22. Bridge JH, Behrson MM, Gonzalez F, Bassingthwaighte JB. Synthesis and use of radio cobaltic EDTA as an extracellular marker in rabbit heart. Am J Physiol 1982; 242:H671-676.
23. Reil GH, Frombach R, Kownatzki R, Quante W, Lichtlen PR. Ascorbic acid: a nonradioactive extracellular space marker in canine heart. Am J Physiol 1987; 253: H1305-1314.
24. Gonzalez F, Bassingthwaighte JB. Heterogeneities in regional volumes of distribution and flows in rabbit heart. Am J Physiol 1990; 258:H1012-1024.
25. Steenbergen C, Hill ML, Jennings RB. Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Circ Res 1985;57:864-875.
26. Zhao M, Zhang H, Robinson TF, Factor SM, Sonnenblick EH, Eng C. Profound structural alterations of the extracellular collagen matrix in postischemic dysfunctional ("stunned") but viable myocardium. J Am Coll Cardiol 1987; 10:1322-1334.
27. Schwitter J, Saeed M, Wendland MF, et al. Influence of severity of myocardial injury on distribution of macromolecules: extravascular versus intravascular gadolinium-based magnetic resonance contrast agents. J Am Coll Cardiol 1997; 30:1086-1094.
28. Freeman I, Grunwald AM, Robin B, Rao PS, Bodenneimer MM. Effect of early reperfusion on use of triphenyltetrazolium chloride to differentiate viable from nonviable myocardium in area of risk. Cardiovasc Res 1990; 24:109-114.
29. Tweedle MF, Wedeking P, Telser J, et al. Dependence of MR signal intensity on Gd tissue concentration over a broad dose range. Magn Reson Med 1991; 22:191-194.
30. Wendland MF, Saeed M, Yu KK, et al. Inversion recovery EPI of bolus transit in rat myocardium using intravascular and extravascular gadolinium-based MR contrast media: dose effects on peak signal enhancement. Magn Reson Med 1994; 32: 319-329.
31. Donahue KM, Weisskoff RM, Burstein D. Water diffusion and exchange as they influence contrast enhancement. JMRI 1997; 7:102-110.
32. Kruhoffer P. Inulin as an indicator for the extracellular space. Acta Physiol Scand 1945; 11:16-36.
33. Kroll H, Korman S, Siegel E, et al. Excretion of yttrium and lanthanum chelates of cyclohexane 1,2-trans diamine tetraacetic acid and dietnylenetriamine pentaacetic acid in man. Nature 1957; 180:919-920.
34. Hauser W, Atkins HL, Nelson KG, Richards P. Technetium-99m DTPA: a new radiopharmaceutical for brain and kidney scanning. Radiology 1970; 94:679-684.
35. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR1984; 142:619-624.
36. Prato FS, Wisenberg GW, Marshall TP, Uksik P, Zabel P. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats. J Nucl Med 1988; 29:1683-1687.
37. 99mTc(DTPA) in rats. Magn Reson Imaging 1990; 8:567-575.
38. 99mTc-DTPA (Sn) dry-kit preparation: quality control and clearance studies. J Nucl Med 1975; 13: 389-399.
39. Holman L. Infarct-avid radiopharmaceuticals: biologic and structural characteristics. In: Strauss H, Pitt B, eds. Cardiovascular nuclear medicine. St Louis, Mo: Mosby, 1979; 255-264.
40. Maddahi J. Infarct-avid imaging in acute myocardial infarction. In: Murray I, Ell P, Strauss H, eds. Nuclear medicine in clinical diagnosis and treatment. Vol 2. New York, NY: Livingstone, 1994; 1207-1217.
41. Weissleder R, Lee AS, Khaw BA, Shen T, Brady TJ. Antimyosin-labeled monocrystalline iron oxide allows detection of myocardial infarct: MR antibody imaging. Radiology 1992; 182:381-385.
42. Marchai G, Ni Y, Herijgers P, et al. Paramagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996; 6:2-8.
43. Polimeni PI, Al-Sadir J. Expansion of extracellular space in the nonischemic zone of the infarcted heart and concomitant changes in tissue electrolyte contents in the rat. Circ Res 1975; 37:725-732.
44. Larsson HBW, Stubgaard M, Sondergaard L, Henriksen O. In vivo quantification of the unidirectional influx constant for Gd-DTPA diffusion across the myocardial capillaries with MR imaging. JMRI 1994; 4:433-440.
45. 99mTc-DTPA for the measurement of glomerular filtration rate. J Nucl Med 1972; 13:107-110.
46. Russell CD, Rowell K, Scott JW. Quality control of technetium-99m DTPA: correlation of analytic tests with in vivo protein binding in man. J Nucl Med 1986; 27:560-562.
47. Donahue KM, Weisskoff RM, Parmelee DJ, et al. Dynamic Gd-DTPA enhanced MRI measurement of tissue cell volume fraction. Magn Reson Med 1995; 34:423-432.